Concepedia

Author

Federica Capozzi

University of TurinORCID

Also Known As

F Capozzi, F. Capozzi, Federica Capozzi

26

Publications

684

Citations

9

H-Index

15

Concepts

All Affiliations

University of TurinCandiolo Cancer InstituteIstituti di Ricovero e Cura a Carattere ScientificoIstituto Ortopedico RizzoliPolytechnic University of Turin
FC

About

Federica Capozzi is an author at University of Turin specializing in cancer therapeutics, radiation oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

359

2

Cell Biology

1

1

31

3

Orthopaedics

1

1

328

4

Pathology

1

1

31

5

Pharmacology

1

1

31

Federica Capozzi

×

8

Publications

657

Citations

8

H-Index

YearCitations

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

Giovanni Grignani, Emanuela Palmerini, Virginia Ferraresi,

The Lancet Oncology

2014

328

The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models

Ymera Pignochino, Carmine Dell’Aglio, Marco Basiricò,

Clinical Cancer Research

2013

107

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models

Ymera Pignochino, Federica Capozzi, Lorenzo D’Ambrosio,

Molecular Cancer

2017

69

Carcinoidal lumor of the Kidney

Frederick G. Zak, K Jindrák, Federica Capozzi

Ultrastructural Pathology

1983

44

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

Ymera Pignochino, Carmine Dell’Aglio, Simona Inghilleri,

BMC Cancer

2015

34

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Giulia Mesiano, Giovanni Grignani, Erika Fiorino,

OncoImmunology

2018

33

Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights

Giulia Chiabotto, Giovanni Grignani, Maja Todorovic,

Cancers

2020

31

DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination

Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero,

Frontiers in Oncology

2022

11

Page 1